Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents
Eleni Sflakidou1, George Leonidis1, Eirini Foroglou1
1Department of Chemistry, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece.
Abstract:
Cancer is one of the top leading causes of death worldwide. It is a heterogenous disease characterized by unregulated cell proliferation and invasiveness of abnormal cells. For the treatment of cancer, natural products have been widely used as a source of therapeutic ingredients since ancient times. Although natural compounds and their derivatives have demonstrated strong antitumor activity in many types of cancer, their poor pharmacokinetic properties, low cell selectivity, limited bioavailability and restricted efficacy against drug-resistant cancer cells hinder their wide clinical application. Conjugation of natural products with other bioactive molecules has given rise to a new field in drug discovery resulting to the development of novel, bifunctional and more potent drugs for cancer therapy to overcome the current drawbacks. This review discusses multiple categories of such bifunctional conjugates and highlights recent trends and advances in the development of natural product hybrids. Among them, ADCs, PDCs, ApDCs, PROTACs and AUTOTACs represent emerging therapeutic agents against cancer.
Insights
Natural products show promise for cancer treatment but face limitations. Conjugating them into novel bifunctional hybrids, like antibody-drug conjugates (ADCs) and PROTACs, enhances efficacy and overcomes resistance for potent cancer therapy.
Area of Science:
- Oncology
- Pharmacology
- Drug Discovery
Background:
- Cancer remains a leading global cause of death, characterized by uncontrolled cell growth.
- Natural products have historical significance in cancer treatment, exhibiting antitumor properties.
- Limitations of natural products include poor pharmacokinetics, low bioavailability, and resistance issues.
Purpose of the Study:
- To review the development of novel bifunctional conjugates derived from natural products for cancer therapy.
- To highlight recent advancements in natural product-based hybrid drug discovery.
- To discuss emerging therapeutic agents like ADCs, PDCs, ApDCs, PROTACs, and AUTOTACs.
Main Methods:
- Literature review of natural product conjugation strategies in cancer drug discovery.
- Analysis of emerging trends in the development of bifunctional natural product hybrids.
- Categorization and discussion of specific conjugate types (ADCs, PDCs, ApDCs, PROTACs, AUTOTACs).
Main Results:
- Conjugation of natural products with other molecules creates novel bifunctional drugs.
- These hybrids aim to improve pharmacokinetic properties, cell selectivity, and overcome drug resistance.
- Specific conjugate classes show significant potential as advanced cancer therapeutics.
Conclusions:
- Bifunctional natural product conjugates represent a promising strategy to enhance cancer treatment efficacy.
- Emerging agents like ADCs, PDCs, ApDCs, PROTACs, and AUTOTACs offer new avenues for combating cancer.
- Further research into these novel hybrids is crucial for clinical translation and improved patient outcomes.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
